These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15202490)
81. Antiviral compounds. 1. Structure-activity relationship of some antiviral enediones derived from aldehydo sugars. Breuer E; Melumad D; Sarel S; Margalith E; Katz E J Med Chem; 1983 Jan; 26(1):30-4. PubMed ID: 6298419 [TBL] [Abstract][Full Text] [Related]
82. Anti-Herpes Simplex Virus Type 1 Activity of Specially Selected Groups of Tannins. Vilhelmova-Ilieva N; Jacquet R; Deffieux D; Pouységu L; Sylla T; Chassaing S; Nikolova I; Quideau S; Galabov AS Drug Res (Stuttg); 2019 Jul; 69(7):374-373. PubMed ID: 30134445 [TBL] [Abstract][Full Text] [Related]
83. Novel benzthiodiazepinones as antiherpetic agents: SAR improvement of therapeutic index by alterations of the seven-membered ring. Hamilton HW; Nishiguchi G; Hagen SE; Domagala JD; Weber PC; Gracheck S; Boulware SL; Nordby EC; Cho H; Nakamura T; Ikeda S; Watanabe W Bioorg Med Chem Lett; 2002 Oct; 12(20):2981-3. PubMed ID: 12270188 [TBL] [Abstract][Full Text] [Related]
84. 2-l-Rhamnopyranosyl[1,2,4]triazolo[1,5-a]pyridine. 4' and 3' Oxidation products. Synthesis and structure-activity relationships. Allard P; Dinh TH; Gouyette C; Igolen J; Chermann JC; Barré-Sinoussi F J Med Chem; 1981 Nov; 24(11):1291-7. PubMed ID: 6273559 [TBL] [Abstract][Full Text] [Related]
85. Antiviral quinolinehydrazones. A modified Free-Wilson analysis. Thomas J; Berkoff CE; Flagg WB; Gallo JJ; Haff RF; Pinto CA J Med Chem; 1975 Mar; 18(3):245-50. PubMed ID: 1133813 [TBL] [Abstract][Full Text] [Related]
86. Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents. Strekowski L; Mokrosz JL; Honkan VA; Czarny A; Cegla MT; Wydra RL; Patterson SE; Schinazi RF J Med Chem; 1991 May; 34(5):1739-46. PubMed ID: 2033597 [TBL] [Abstract][Full Text] [Related]
87. Spectrum and characteristics of the virus-inhibitory action of two isoquinoline derivatives. Larin NM; Beare AS; Copping MP; McDonald CR; McDougall JK; Roberts B; Smith JB Antimicrob Agents Chemother (Bethesda); 1967; 7():646-53. PubMed ID: 4970206 [No Abstract] [Full Text] [Related]
88. Synthesis and antiviral activities of N-mono- and/or N,N'-di-carbamoyl and acyl derivatives of symmetrical diamines. Mibu N; Yokomizo K; Oishi M; Miyata T; Sumoto K Chem Pharm Bull (Tokyo); 2008 Jul; 56(7):1052-8. PubMed ID: 18591833 [TBL] [Abstract][Full Text] [Related]
89. Engineering of Janus-Like Dendrimers with Peptides Derived from Glycoproteins of Herpes Simplex Virus Type 1: Toward a Versatile and Novel Antiviral Platform. Falanga A; Del Genio V; Kaufman EA; Zannella C; Franci G; Weck M; Galdiero S Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204295 [TBL] [Abstract][Full Text] [Related]
90. An overview on synthetic methodologies and biological activities of pyrazoloquinolines. Gaurav A; Gautam V; Singh R Mini Rev Med Chem; 2010 Nov; 10(13):1194-210. PubMed ID: 20854254 [TBL] [Abstract][Full Text] [Related]
91. Synthesis and antiherpetic activity of some 4-[(aryloxy)alkyl]pyrazoles. Diana GD; Carabateas PM; Williams GL; Pancic F; Steinberg BA J Med Chem; 1981 Jun; 24(6):731-5. PubMed ID: 6265636 [No Abstract] [Full Text] [Related]
93. Considerations on structure-activity relationships with mengovirus of substituted 5-amino-4-cyanopyrazoles. Willitzer H; Tonew M; Lippmann E Antimicrob Agents Chemother; 1976 Mar; 9(3):367-70. PubMed ID: 176931 [TBL] [Abstract][Full Text] [Related]
94. Phosphoanalogues of amino acids involved in methionine metabolism as a new source of antiviral compounds. Khomutov RM; Shchipanova AI; Khurs EN Dokl Biochem Biophys; 2009; 425():84-6. PubMed ID: 19496328 [No Abstract] [Full Text] [Related]
95. Potential antidiabetics. 9. Biological activity of some pyrazoles. Garg HG; Prakash C J Med Chem; 1971 Jul; 14(17):649-50. PubMed ID: 4365201 [No Abstract] [Full Text] [Related]
96. A simple convergent approach to the synthesis of the antiviral agent virantmycin. Steinhagen H; Corey EJ Org Lett; 1999 Sep; 1(5):823-4. PubMed ID: 10823211 [TBL] [Abstract][Full Text] [Related]
97. 1 Danel A; Gondek E; Kucharek M; Szlachcic P; Gut A Molecules; 2022 Apr; 27(9):. PubMed ID: 35566124 [TBL] [Abstract][Full Text] [Related]
98. Evaluation of cytotoxic potential of newly synthesized antiviral aminopyrazoloquinoline derivatives. Arif JM; Kunhi M; Subramanian MP; Bekhit AA; El-Sayed OA; Al-Hussein K; Aboul-Enein HY; Al-Khodairy FM Int J Biomed Sci; 2007 Sep; 3(3):194-8. PubMed ID: 23675043 [TBL] [Abstract][Full Text] [Related]
99. Synthesis of aldehydo-sugar derivatives of pyrazoloquinoline as inhibitors of herpes simplex virus type 1 replication. Bekhit AA; El-Sayed OA; Aboul-Enein HY; Siddiqui YM; Al-Ahdal MN J Enzyme Inhib Med Chem; 2004 Feb; 19(1):33-8. PubMed ID: 15202490 [TBL] [Abstract][Full Text] [Related]
100. Evaluation of some pyrazoloquinolines as inhibitors of herpes simplex virus type 1 replication. Bekhit AA; El-Sayed OA; Aboul-Enein HY; Siddiqui YM; Al-Ahdal MN Arch Pharm (Weinheim); 2005 Mar; 338(2-3):74-7. PubMed ID: 15736285 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]